small cell lung carcinoma
Showing 26 - 50 of 70
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)
Not yet recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Mycophenolate Mofetil
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
May 17, 2022
Small Cell Lung Carcinoma Trial in Greece (Avelumab)
Active, not recruiting
- Small Cell Lung Carcinoma
-
Chaïdári, Athens, Greece
- +5 more
Apr 18, 2022
Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)
Active, not recruiting
- Small Cell Lung Carcinoma
- IP chemotherapy
- IP chemotherapy plus simvastatin
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center , Korea
Apr 4, 2022
Locally Advanced Lung Carcinoma, Non-Small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Buffalo (Porfimer Sodium,
Recruiting
- Locally Advanced Lung Carcinoma
- +6 more
- Porfimer Sodium
- Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 14, 2022
Small Cell Lung Carcinoma Trial in Omaha (Durvalumab + Tremelimumab in combination with carboplatin and etoposide, Durvalumab in
Terminated
- Small Cell Lung Carcinoma
- Durvalumab + Tremelimumab in combination with carboplatin and etoposide
- Durvalumab in combination with carboplatin and etoposide
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 24, 2022
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Not yet recruiting
- Non Small Cell Lung Cancer
- Small Cell Lung Carcinoma
- Data and Specimen Collection
-
Boston, Massachusetts
- +3 more
Feb 22, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Small Cell Lung Carcinoma Trial in Guangzhou (Surufatinib,Etoposide,Cisplatin,Toripalimab, Surufatinib,Etoposide,Cisplatin)
Recruiting
- Small Cell Lung Carcinoma
-
Guangzhou, Guang Dong, ChinaSun Yat-sen University Cancer Center
Dec 23, 2021
Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique
Completed
- Non-small Cell Lung Carcinoma
- Small Cell Lung Carcinoma
- Contralateral Esophageal Sparing Technique (CEST)
-
Boston, Massachusetts
- +1 more
Dec 8, 2021
Small Cell Lung Carcinoma Trial in Zhengzhou (Camrelizumab Plus Apatinib)
Recruiting
- Small Cell Lung Carcinoma
- Camrelizumab Plus Apatinib
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Nov 24, 2021
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Augusta (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Irinotecan
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
- Irinotecan Injection [Camptosar]
-
Augusta, GeorgiaGeorgia Cancer Center at AU Medical Center
Jul 31, 2021
Small Cell Lung Carcinoma Trial in Barcelona (Prophylactic cranial irradiation (PCI), Hippocampal avoidance PCI)
Completed
- Small Cell Lung Carcinoma
- Prophylactic cranial irradiation (PCI)
- Hippocampal avoidance PCI
-
Barcelona, SpainHospital Del Mar. Radiation Oncology Department
Jul 27, 2021
Small Cell Lung Carcinoma Trial in France, Korea, Republic of, United States (Roniciclib (BAY1000394), Etoposide, Cisplatin)
Terminated
- Small Cell Lung Carcinoma
- Roniciclib (BAY1000394)
- +3 more
-
Saint Louis, Missouri
- +7 more
Apr 6, 2021
Small Cell Lung Carcinoma Trial in Beijing (Tislelizumab, Anlotinib HCl)
Recruiting
- Small Cell Lung Carcinoma
- Tislelizumab
- Anlotinib hydrochloride
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Nov 6, 2020
Small Cell Lung Carcinoma Trial in Worldwide (Ipilimumab, Placebo matching Ipilimumab, Etoposide)
Completed
- Small Cell Lung Carcinoma
- Ipilimumab
- +4 more
-
Hot Springs, Arkansas
- +224 more
Jul 6, 2020
Small Cell Lung Carcinoma Trial in Beijing (Camrelizumab,an engineered anti-PD-1 antibody, Platinum, Irinotecan)
Recruiting
- Small Cell Lung Carcinoma
- Camrelizumab,an engineered anti-PD-1 antibody
- +3 more
-
Beijing, ChinaBeijing Union Medical College Hospital
Jun 28, 2020
Small Cell Lung Carcinoma Trial in Taizhou (Etoposide Injection, Carboplatin Injection, Cisplatin injection)
Not yet recruiting
- Small Cell Lung Carcinoma
- Etoposide Injection
- +4 more
-
Taizhou, Zhejiang, China
- +1 more
Apr 26, 2020
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Terminated
- Non-small Cell Lung Cancer Metastatic
- Small Cell Lung Carcinoma
- therapeutic interventions
- (no location specified)
Jan 7, 2020
Small Cell Lung Carcinoma Trial in Guangzhou (Anlotinib Hydrochloride, Lobaplatin, Etoposide)
Unknown status
- Small Cell Lung Carcinoma
- Anlotinib Hydrochloride
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Guangzhou Medical University
Nov 26, 2019
Esophageal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Rochester, Omaha, Green Bay (Doxepin Hydrochloride,
Terminated
- Esophageal Carcinoma
- +13 more
- Doxepin Hydrochloride
- +3 more
-
Rochester, Minnesota
- +2 more
Sep 10, 2019